Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heart and Estrogen-Progestin Replacement Study (HERS)
NCT00319566Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 1992
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of medroxyprogesterone acetate in coronary heart disease (CHD), sponsored by University of California, San Francisco. Started Jul 1992; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00319566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319566.